Imprime PGG in Combination with Monoclonal Antibody Therapy Achieves 64 ... MarketWatch (press release) Research shows that early monoclonal antibody (mAb) therapy with alemtuzumab and rituximab is effective and could possibly delay first standard treatment (Cancer 2008; 113:2110-8). Furthermore, the efficacy of this therapy could be improved by ... |
